1304 related articles for article (PubMed ID: 18855267)
1. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
[TBL] [Abstract][Full Text] [Related]
3. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
[TBL] [Abstract][Full Text] [Related]
5. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.
Gallay BJ; Ahmad S; Xu L; Toivola B; Davidson RC
Am J Kidney Dis; 2001 Apr; 37(4):699-705. PubMed ID: 11273868
[TBL] [Abstract][Full Text] [Related]
6. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of hyperaldosteronism in the hypertensive patient. Why? When? How?].
Herpin D; Sosner P; Amar J; Chamontin B
Arch Mal Coeur Vaiss; 2003 Jan; 96(1):37-42. PubMed ID: 12613148
[TBL] [Abstract][Full Text] [Related]
8. A case of primary aldosteronism with a negative aldosterone-to-renin ratio.
Liu F; Wang L; Ding Y
BMC Cardiovasc Disord; 2021 Jul; 21(1):350. PubMed ID: 34294029
[TBL] [Abstract][Full Text] [Related]
9. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
[TBL] [Abstract][Full Text] [Related]
10. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
Omura M; Nishikawa T
Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
[TBL] [Abstract][Full Text] [Related]
11. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
[TBL] [Abstract][Full Text] [Related]
12. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity.
Lim PO; Jung RT; MacDonald TM
J Hum Hypertens; 2002 Mar; 16(3):153-8. PubMed ID: 11896503
[TBL] [Abstract][Full Text] [Related]
13. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
[TBL] [Abstract][Full Text] [Related]
14. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
[TBL] [Abstract][Full Text] [Related]
15. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
16. Captopril suppression: limitations for confirmation of primary aldosteronism.
Westerdahl C; Bergenfelz A; Isaksson A; Valdemarsson S
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):326-32. PubMed ID: 21273222
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of primary hyperaldosteronism].
Diederich S; Bidlingmaier M; Quinkler M; Reincke M
Med Klin (Munich); 2007 Jan; 102(1):16-21. PubMed ID: 17221347
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.
Fogari R; Preti P; Zoppi A; Rinaldi A; Fogari E; Mugellini A
Hypertens Res; 2007 Feb; 30(2):111-7. PubMed ID: 17460380
[TBL] [Abstract][Full Text] [Related]
20. Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism.
Rossi GP; Chiesura-Corona M; Tregnaghi A; Zanin L; Perale R; Soattin S; Pelizzo MR; Feltrin GP; Pessina AC
J Hum Hypertens; 1993 Aug; 7(4):357-63. PubMed ID: 8410926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]